In 2023, the MCV2 immunization coverage in Japan stood at 95% among children of the nationally recommended age. The forecast data from 2024 to 2028 indicates a consistent coverage rate of 95%, with no year-on-year percentage variation. This stability suggests a strong maintenance of current immunization levels, reflecting effective public health policies and significant public trust in the vaccination program.

Future trends to watch include:

The impact of potential public health initiatives aiming to improve or maintain vaccine compliance.
Societal shifts or health crises that could influence vaccination rates.
Technological advances in vaccine delivery or monitoring that could enhance coverage.